Cas:1093819-50-1 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine manufacturer & supplier

Chemical Name:5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine

CAS.NO:1093819-50-1

Synonyms:1H-Pyrazolo[3,4-b]pyridine-5-boronic acid pinacol ester;1H-Pyrazolo[3,4-b]pyridine, 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine

Molecular Formula:C₁₂H₁₆BN₃O₂

Molecular Weight:245.085

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:414.6±25.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.565

PSA:60.03000

Exact Mass:245.133560

LogP:1.25710

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-Pyrazolo[3,4-b]pyridine-5-boronic acid pinacol ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazolo[3,4-b]pyridine-5-boronic acid pinacol ester Use and application,1H-Pyrazolo[3,4-b]pyridine-5-boronic acid pinacol ester technical grade,usp/ep/jp grade.

Related News: An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine manufacturer In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed. 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine supplier In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed. 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine vendor Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine factory The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.